Felix Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Felix Biotechnology's estimated annual revenue is currently $1.1M per year.
- Felix Biotechnology's estimated revenue per employee is $155,000
Employee Data
- Felix Biotechnology has 7 Employees.
- Felix Biotechnology grew their employee count by -42% last year.
Felix Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Scientist | Reveal Email/Phone |
Felix Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Felix Biotechnology?
In collaboration with researchers at Yale University and UC Berkeley, Felix Biotechnology is focused on accelerating the deployment of novel biotherapeutics targeting urgent microbial challenges in human health and beyond.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
-42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Felix Biotechnology News
2022-04-17 - BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone
Pellet, BICX104, with The Stock Day Podcast
"We have been in business now for over ten years," said Felix. ... and went into biotechnology and pharmaceuticals in 2016," she continued.
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | 17% | $40.4M |
#2 | $0.1M | 7 | -42% | $13.2M |
#3 | $0.5M | 7 | 0% | N/A |
#4 | $0.1M | 7 | 0% | $105.6M |
#5 | $0.1M | 7 | 0% | $15.3M |